1. Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumors. Issue 8 (8th February 2017) Authors: Peverelli, E.; Giardino, E; Treppiedi, D.; Meregalli, M.; Belicchi, M.; Vaira, V.; Corbetta, S.; Verdelli, C.; Verrua, E.; Serban, A. L.; Locatelli, M.; Carrabba, G.; Gaudenzi, G.; Malchiodi, E.; Cassinelli, L.; Lania, A. G.; Ferrero, S.; Bosari, S.; Vitale, G.; Torrente, Y. Journal: International journal of cancer Issue: Volume 140:Issue 8(2017:Apr. 15) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P849: DEPLETION OF DIS3 IN MULTIPLE MYELOMA LEADS TO PERTURBATION IN RNA METABOLISM, CELL CYCLE PROGRESSION AND MITOTIC CHECKPOINT. (23rd June 2022) Authors: Favasuli, V.; Silvestris, I.; Todoerti, K.; Ronchetti, D.; Erratico, S.; giannandrea, D.; Torrente, Y.; Chiaramonte, R.; Fabbris, S.; Bolli, N.; Baldini, L.; Neri, A.; Taiana, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P875: ACTIVATION OF LNCRNA NEAT1 LEADS TO SURVIVAL ADVANTAGE OF MULTIPLE MYELOMA CELLS BY SUPPORTING A REGULATORY LOOP WITH DNA REPAIR PROTEINS: RATIONAL BASES FOR NEAT1 THERAPEUTIC TARGETING IN THE DISEASE. (23rd June 2022) Authors: Taiana, E.; Ronchetti, D.; Favasuli, V. K.; Silvestris, I.; Puccio, N.; Todoerti, K.; Bandini, C.; Craparotta, I.; Di Rito, L.; Erratico, S.; Giannandrea, D.; Piva, R.; Bolis, M.; Torrente, Y.; Chiaramonte, R.; Bolli, N.; Baldini, L.; Neri, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗